Welcome to a Citations Needed News Brief. I am Neem Asherazi.

I'm Adam Johnson.

We do these newsreads in between our regularly scheduled episodes of Citations Needed,

when the news just calls for the hottest of takes that we could possibly give.

But of course, you can follow the show on Twitter at CitationsPod Facebook, Citations

Needed, and become a supporter of our work through patreon.com slash Citations Needed

Podcast with Neem Asherazi and Adam Johnson. All your support through Patreon is so incredibly

appreciated. We are 100% listed funded. And so your support goes such a long way. Adam,

I feel like we really need to get to what we're going to talk about quick. We're going to cut

out any kind of superfluous intro because there is breaking news regarding the trips waiver

about intellectual property as it pertains to COVID-19 vaccines. And we have been following

this, I would say fairly closely as closely as we tend to follow things and doing a number

of follow-ups to our episode on intellectual property. And the day that we are recording

this May 5, 2021, there is late breaking news.

Yeah, so the Biden administration has come out in nominal support of a trips waiver. It

is being reported as supporting by many people, as supporting the trips waiver, as is

popularly known, primarily proposed by India and South Africa, that cause for a blanket, very

broad IP exemption under the emergency car vouts for anything involving COVID or COVID-19

related. So it's a blanket waiver, blanket patent suspension. And a statement released by

US Trade Representative Catherine Ty claimed that the US supports a waving of intellectual

property as it pertains to the vaccines. Did not mention anything about the other materials

and tech support that the broader waiver called for. So what we have here is a situation

...